Varicella zoster virus reactivation after coronavirus disease 2019 vaccination in Japanese patients: A series of 14 cases.

Ibuchi, Yoshiaki; Tamayose, Fumiko; Katayama, Hiroki; Saeki, Hidehisa; Osada, Shin-Ichi

Ibuchi, Yoshiaki; Tamayose, Fumiko; Katayama, Hiroki; Saeki, Hidehisa; Osada, Shin-Ichi.

Ibuchi Y; Department of Dermatology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Tamayose F; Department of Dermatology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Katayama H; Department of Dermatology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Saeki H; Department of Dermatology, Nippon Medical School, Tokyo, Japan.
Osada SI; Department of Dermatology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.

J Dermatol ; 49(5): e151-e153, 2022 05.

Article in English | MEDLINE | ID: covidwho-1583730

Subject(s)

COVID-19; Chickenpox; Herpes Zoster; COVID-19/prevention & control; Herpes Zoster/prevention & control; Herpesvirus 3, Human/physiology; Humans; Japan/epidemiology; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chickenpox / COVID-19 / Herpes Zoster Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: J Dermatol Year: 2022 Document Type: Article Affiliation country: 1346-8138.16287

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google